Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide
JY Hor, N Asgari, I Nakashima, SA Broadley… - Frontiers in …, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …
The prevalence of MS in the United States: a population-based estimate using health claims data
MT Wallin, WJ Culpepper, JD Campbell, LM Nelson… - Neurology, 2019 - AAN Enterprises
Objective To generate a national multiple sclerosis (MS) prevalence estimate for the United
States by applying a validated algorithm to multiple administrative health claims (AHC) …
States by applying a validated algorithm to multiple administrative health claims (AHC) …
Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Background Multiple sclerosis is the most common inflammatory neurological disease in
young adults. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) …
young adults. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) …
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
Background The cause of multiple sclerosis is believed to involve environmental exposure
and genetic susceptibility. We aimed to summarise the environmental risk factors that have …
and genetic susceptibility. We aimed to summarise the environmental risk factors that have …
Epidemiology of multiple sclerosis
J Howard, S Trevick, DS Younger - Neurologic clinics, 2016 - neurologic.theclinics.com
The Americas In 2007, Poser and Brinar 1 noted that published prevalence rates of multiple
sclerosis (MS) could be misleading with the reliance on clinical information and brain MRI …
sclerosis (MS) could be misleading with the reliance on clinical information and brain MRI …
Regulatory T cells in multiple sclerosis and myasthenia gravis
KM Danikowski, S Jayaraman… - Journal of …, 2017 - Springer
Multiple sclerosis (MS) is a chronic debilitating disease of the central nervous system
primarily mediated by T lymphocytes with specificity to neuronal antigens in genetically …
primarily mediated by T lymphocytes with specificity to neuronal antigens in genetically …
[HTML][HTML] Multiple sclerosis, a treatable disease
A Doshi, J Chataway - Clinical Medicine, 2017 - ncbi.nlm.nih.gov
This article reviews our current understanding and modern treatment of multiple sclerosis
(MS). MS is a disabling condition resulting in devastating social and economic impacts. As …
(MS). MS is a disabling condition resulting in devastating social and economic impacts. As …
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review
D Karussis - Journal of autoimmunity, 2014 - Elsevier
Multiple sclerosis (MS), is a chronic disease of the central nervous system (CNS)
characterized by loss of motor and sensory function, that results from immune-mediated …
characterized by loss of motor and sensory function, that results from immune-mediated …
Virtual reality in multiple sclerosis rehabilitation: A review on cognitive and motor outcomes
MG Maggio, M Russo, MF Cuzzola, M Destro… - Journal of Clinical …, 2019 - Elsevier
Multiple sclerosis (MS) is a demyelinating neurodegenerative disease with lesions involving
the central nervous system. Clinical symptoms consist of disturbances in motor activity (eg …
the central nervous system. Clinical symptoms consist of disturbances in motor activity (eg …